Health TrialsbyHealthPanel

Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers

ConditionSmoking
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorHospital St. Joseph, Marseille, France

About this trial

Diagnostic performance of low-dose chest CT scan combined with lung-RADS classification (version 1.1) for lung cancer screening among former and current smokers.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Male or female 50-80 years old

Active smoker (≥ 15 PA) or former smoker (≥ 15 PA)

Disqualifiers

Recent history of chest CT scan (within 12 months)

Person unable to climb 2 floors

Weight > 140kg

Personal history of cancer < 5 years (currently being monitored by thoracic imaging)

Trial design

Design model

Single group

Treatments tested in this trial

  • Low-dose chest CT scan

    Diagnostic test

    baseline, 1-year, 3-year and 5-year low-dose CT scan

Treatment groups

1,000 Participants
are divided into 1 treatment group
Group A: CT scanExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Positive Predictive Value (PPV)

Time frame
5 years

Secondary outcomes

1

Sensitivity

Time frame
5 years
2

Specificity

Time frame
5 years
3

Early stage lung cancer detection rate (stage I and II)

Time frame
5 years
4

5-year survival rate of patients who have undergone thoracic surgery

Time frame
5 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Hospital St. Joseph, Marseille, France

Lead sponsor

Source ClinicalTrials.gov
Apply now